Tetracycline
Tetracycline is used to treat infections caused by certain bacteria.
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.32 | $57.00 (0%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $114.00 $104.00 (9%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.00 (0%) | 🛒 Add to cart |
| 90 | $0.63 | $64.50 $57.00 (12%) | 🛒 Add to cart |
| 120 | $0.58 | $86.00 $70.00 (19%) | 🛒 Add to cart |
| 180 | $0.54 | $129.00 $98.00 (24%) | 🛒 Add to cart |
| 270 | $0.51 | $193.50 $139.00 (28%) | 🛒 Add to cart |
| 360 | $0.51
Best per pill | $258.00 $182.00 (29%) | 🛒 Add to cart |
Similar products
More info:
Ferrous Sulfate: Restore Iron Levels for Optimal Health
Ferrous sulfate is an essential mineral supplement indicated for the prevention and treatment of iron deficiency and iron deficiency anemia. As the most bioavailable form of supplemental iron, it plays a critical role in hemoglobin synthesis, oxygen transport, and cellular energy production. Clinical use is supported by decades of evidence demonstrating efficacy in restoring iron stores, improving hematological parameters, and alleviating symptoms associated with deficiency. Proper dosing, monitoring, and patient education are fundamental to achieving therapeutic outcomes while minimizing adverse effects.
PhosLo: Advanced Phosphate Control for Renal Health
PhosLo (calcium acetate) is a prescription phosphate binder specifically formulated for the management of hyperphosphatemia in patients with end-stage renal disease. By effectively reducing serum phosphate levels, it plays a critical role in mitigating the risk of renal osteodystrophy and cardiovascular calcification. This medication is a cornerstone in nephrology care, supporting long-term patient outcomes through precise biochemical management. Features Active ingredient: Calcium acetate Available in 667 mg tablets Functions as a phosphate binder in the gastrointestinal tract Designed for oral administration with meals Manufactured under strict pharmaceutical quality standards Prescription-only medication Benefits Effectively lowers serum phosphate levels in dialysis patients Reduces the risk of secondary hyperparathyroidism and bone disease Helps prevent soft tissue and vascular calcification Supports overall mineral and bone disorder management in CKD May decrease mortality associated with hyperphosphatemia complications Provides predictable phosphate binding with meal consumption Common use PhosLo is primarily indicated for the control of hyperphosphatemia in patients with end-stage renal disease who are on dialysis.
Abhigra: Advanced Treatment for Erectile Dysfunction
Abhigra is a clinically validated pharmaceutical agent designed to address erectile dysfunction (ED) with precision and reliability. Formulated with sildenafil citrate as its active ingredient, it functions by enhancing blood flow to the penile tissues, facilitating sustainable and satisfactory erections. This medication is intended for adult males experiencing difficulties in achieving or maintaining an erection sufficient for sexual activity. Supported by extensive research and adherence to stringent manufacturing standards, Abhigra offers a trusted solution for improving sexual health and quality of life.
Alprostadil: Restoring Natural Erections for Erectile Dysfunction
Alprostadil is a synthetic prostaglandin E1 analog used primarily in the treatment of erectile dysfunction (ED). As a vasodilator, it works by relaxing smooth muscle tissue and dilating cavernosal arteries, thereby increasing blood flow into the penis to facilitate an erection. This medication is available in several administration forms, including intracavernosal injection, intraurethral pellet, and topical cream, offering flexibility based on patient preference and clinical suitability. It represents a well-established, effective second-line therapy for men who do not respond to or cannot use oral phosphodiesterase type 5 inhibitors.
Androxal: Clinically Validated Testosterone Restoration Therapy
Androxal (enclomiphene citrate) represents a significant advancement in the treatment of male hypogonadism, specifically for men with secondary hypogonadism. Unlike traditional testosterone replacement therapies (TRT) which often suppress natural hormone production and can impair fertility, Androxal works through a novel mechanism of action. It stimulates the hypothalamic-pituitary-gonadal (HPG) axis to promote the body’s own endogenous testosterone production. This profile provides a comprehensive, evidence-based overview of its specifications, clinical application, and safety data for healthcare professionals.
Apcalis SX Oral Jelly: Fast-Acting Erectile Dysfunction Relief
Apcalis SX Oral Jelly is a specialized phosphodiesterase type 5 (PDE5) inhibitor formulated for the treatment of erectile dysfunction. It contains Tadalafil as its active pharmaceutical ingredient, delivered in a convenient, palatable oral jelly format for rapid absorption and predictable pharmacokinetics. This formulation is designed to offer a reliable therapeutic option with an onset of action typically within 15–30 minutes, supporting spontaneity and reducing planning-related anxiety. It is intended for adult male use under appropriate medical supervision.
Aurogra: Effective Treatment for Erectile Dysfunction
Aurogra is a prescription medication specifically formulated to address erectile dysfunction (ED) in adult men. It contains Sildenafil Citrate, a potent phosphodiesterase type 5 (PDE5) inhibitor that enhances blood flow to the penile tissues, facilitating the achievement and maintenance of an erection sufficient for sexual activity. This medication is clinically proven, requires sexual stimulation for efficacy, and should be used under appropriate medical supervision to ensure safety and optimal therapeutic outcomes.
Avana: Advanced PDE5 Inhibition for Confident Erection Control
Avana (avanafil) is a next-generation phosphodiesterase type 5 (PDE5) inhibitor engineered for rapid onset and sustained efficacy in the treatment of erectile dysfunction. Its highly selective mechanism targets the cavernosal smooth muscle with precision, facilitating robust nitric oxide-mediated vasodilation while minimizing off-target effects. Clinically validated for reliability and patient satisfaction, Avana represents a refined therapeutic option for men seeking predictable erectile response with favorable tolerability. This agent combines pharmacokinetic advantages with a well-characterized safety profile, making it a cornerstone in modern sexual medicine protocols.
Betahistine: Effective Vertigo and Meniere's Disease Symptom Control
Betahistine is a histamine analogue specifically indicated for the management of vestibular disorders, most notably vertigo associated with Meniere’s disease. It functions as a histamine H1-receptor agonist and H3-receptor antagonist, improving microvascular circulation in the inner ear and reducing endolymphatic pressure. This pharmacological profile makes it a cornerstone therapy for patients experiencing debilitating episodes of dizziness, tinnitus, and hearing loss. Clinical use is supported by guidelines for symptomatic control and improvement in quality of life.